It has a better profile regarding glucose tolerance than direct GH administration
Two phase II trials - one in a population with obesity (without T2D) [45], and a second in a population with T2D and overweight/obesity [46], have recently been published and their key findings are presented below (Table 1)
Efficacy: Semaglutide has superior reductions in HbA1c and body weight compared to other agents, while tirzepatide, a dual GLP-1/GIP receptor agonist, shows even greater efficacy but with higher rates of adverse events
Anderson ME (1985)
Mandie was absolutely amazing, so detail-oriented, honest, and professional
Fitness trackers and smartwatches monitor physical activity, heart rate, and sleep patternsall relevant to overall health outcomes